Category Archives: Genetic Engineering

Feature Article of Monday, 17 February 2014

Columnist: Agorsor, Yafetto, Otwe, Galyuon

Israel D. K. Agorsor, Levi Yafetto, Emmanuel P. Otwe and Isaac K. A. Galyuon This is the concluding part of the articles Ghanas GMO debates: beyond the sticking points (1) & (2)

6. Interfering in Nature As we indicated in the first part of this article, one of the moral arguments against GMOs is that the processes leading to them, that is, genetic engineering techniques, amount to gross interference in nature and the natural order. Here, we present scientific arguments that say that this may not be restricted to GMOs alone, as humankind has always interfered in nature, at times in ways unimaginable, all in an effort to make life better.

You may be surprised to hear that many of the food crops we eat today are not their original selves. They are products of years of conscious and systematic manipulation of nature, if you will call it that, representing a marked departure from what they were in the beginning of time. Humankind has always attempted to improve natural resources to meet the demands of a growing population in a changing climate. That is to say that conventional breeding itself relies on the transfer of genes, albeit via crosses. from one crop species to a related species in order to be able to develop new varieties.

Conventional plant breeding has its own problems. Unlike genetic engineering, conventional breeding in transferring a gene which conditions a specific trait also transfers a number of other genes on the same chromosome along with it. This means that the conventional breeder very often is not only transferring a specific trait to his elite cultivated variety (cultivar), but also other traits that may be undesirable. For example, two varieties of conventionally-bred potatoes, Lenape and Magnum Bonum, and conventionally-bred celery developed to be pest-resistant had to be withdrawn from the market after it was realized that the conventional breeding processes accidentally led to increased levels of naturally occurring toxins in them.

The foregoing explains why some scientists argue that the assumption that conventionally-bred crops are necessarily safer than GM crops is overly simplistic, especially when conventionally-bred crops are not subjected to the kind of pre-marketing safety analysis done for GM crops.

Then, we present another interference in nature: mutation breeding. Mutation breeding is a crop breeding technique where breeders subject seeds to doses of radiation and gene-altering chemicals in order to produce novel plant varieties. This technique has been in use since the dawn of the nuclear age in the 1950s, and has seen an escalated use in the last few years. The Nuclear Techniques in Food and Agriculture programme of the United Nations reportedly received about 40 requests for radiation services from a number of countries across the world in 2013. Many of the multinational seed companies chided for promoting GMOs, like BASF and Monsanto, have all reportedly used this technique in developing new crop varieties, all without regulation.

In Ghana, the Biotechnology and Nuclear Agriculture Research Institute (BNARI) of the Ghana Atomic Energy Commission, and research programmes in some of the nations universities, the University of Cape Coast for example, have been experimenting mutation breeding techniques for some time now.

In a 2004 report, the US National Academy of Sciences remarked that placing GM crops under tight regulations, while approving products of mutation breeding without any regulation, cannot be justified by science. Mutagenesis, the technique underpinning mutation breeding, has the capacity to rearrange or delete hundreds of genes randomly. It makes use of tools such as gamma radiation, which give rise to mutations (i.e., changes in an organisms genetic make-up) that sometimes are beneficial or hazardous to the organism. If you have ever had an X-ray image of any part of your body taken, then you have been exposed to radiation. And it is precisely because of the possibility of this process introducing mutations into your genetic make-up you are advised against taking X-ray images very frequently.

The rest is here:
Ghanas GMO debates: beyond the sticking points (3)

Genetic Engineering and Glowing Kitties ofDOOM!

By: Myles Power (mirror)

Follow this link:
Genetic Engineering and Glowing Kitties ofDOOM! - Video

FoodYou Design: BioEthics Forum XX
Feelings, Facts, Food and GMOs -- A Fresh Look The mission of the FoodYou Campaign at Pace University is to objectively explore and address the tough que...

By: ThePaceAcademy

See more here:
FoodYou Design: BioEthics Forum XX - Video

Feature Article of Thursday, 13 February 2014

Columnist: Agorsor, Yafetto, Otwe, Galyuon

Israel D. K. Agorsor, Levi Yafetto, Emmanuel P. Otwe and Isaac K. A. Galyuon

1. Introduction

At the turn of the last decade, Ghana signaled its intention to adopt plant genetic engineering as part of the efforts towards modernizing its agriculture when it established the National Biosafety Committee. This committee would, among others, activate the processes for the formulation of a Biosafety Bill. In 2011, a draft Biosafety Bill was passed into law by Ghanas Parliament, and is known as Biosafety Act 2011 or Act 831. Genetic engineering techniques enable scientists to modify the genetic make-up of an organism, otherwise known as its genome, by inserting into the genome pieces of deoxyribonucleic acid (DNA) ? the genetic material ? that condition specific desirable traits from other organisms. These modifications result in what are known as genetically modified organisms (GMOs) or transgenic organisms (transgenics).

To say that the debates on GMOs are, perhaps, the fiercest of all debates that have ever engulfed any human endeavour and, for that matter, any scientific discipline in living memory may be an understatement. Why the GMO wars have been so fiercely fought is clear only to the extent that people and cultures have significant emotional attachment to food and food products, and thus anything that appears an aberration to these would always be fiercely resisted. However, the evidence, as we have it, is that these debates have at times gone beyond the science, and have assumed moral and speculative dimensions. The result is that quite often, moral questions are also asked to proponents of genetic engineering, questions whose answers may not be readily available.

Some of these moral questions include: Are scientists now playing God? Why do scientists interfere in nature and the natural order? Speculative ones include the myriad of diseases, such as cancer, heart diseases, diabetes and fibroid, that genetically modified (GM) food causes. Of course we are aware of some published reports which suggest GM foods could have adverse effects on human and animal health. But we are also aware that some of these reports have either been challenged or retracted from the scientific journals in which they were published after follow-up studies showed that the experiments leading to those conclusions were flawed. You may read, for example, Sralini affair at http://en.wikipedia.org/wiki/S%C3%A9ralini_affair, as well as the widely-referenced Pusztai study which although hailed by some scientists, has been challenged by others including the UK Royal Society. See the Pusztai affair at http://en.wikipedia.org/wiki/Pusztai_affair.

We have noticed, too, that in an opinion piece that appeared in the Daily Graphic of Monday, December 23, 2013, and titled GM Foods: Mass genocide, studies by Australian scientist Judy Carman and her colleague Jack Heinemann have been cited as evidence of health risks of GMOs. In fact, Carman and co-authors studies have been disputed. Many scientists, including the food regulator for Australia/New Zealand known as Food Standards Australia and New Zealand (FSANZ) have rejected Carman and colleagues claim that GM foods have health risks as reported in one study. See FSANZs response to Carman and colleagues claims at http://www.foodstandards.gov.au/consumer/gmfood/Pages/Response-to-Dr-Carman's-study.aspx. Basically, the charge is that it was flawed science that led to their claims.

For an example of a publication that discusses the health implications of GM foods, see the article (not an original research paper, but a review article) Health risks of genetically modified foods by Dona and Arvanitoyannis published in the journal Critical Reviews in Food Science and Nutrition in 2009 (Crit Rev Food Sci Nutr 49(2): 164-175) at http://www.ncbi.nlm.nih.gov/pubmed/18989835 (click on View full text). For a challenge to the views expressed in Dona and Arvanitoyannis, see the article Response to Health risks of genetically modified foods by Craig Rickard in the same journal at http://www.tandfonline.com/doi/full/10.1080/10408390903467787#tabModule.

Unfortunately, the independence of the authors of some of the pro- and anti-GMO articles and research papers have been questioned at times; the authors have been accused of doing the bidding of either biotechnology giants or anti-GMO movements because they have been receiving, allegedly, research funding from these groups. These accusations have also added to the complexity of the GMO debates.

Read the original here:
Ghanas GMO debates: beyond the sticking points (1)

Genetic Engineering Maximum Ride Style
Abigail Rasch #39;s "Science in Fiction" Video Contest submission ( can also be viewed here: https://www.wevideo.com/view/151007082)

By: Kavli "Science in Fiction" Video Channel

See more here:
Genetic Engineering Maximum Ride Style - Video

PARIS, Feb 13 (BERNAMA-NNN-PRENSA LATINA) -- French company Abivax and the Centre for Genetic Engineering and Biotechnology (CIGB) in Cuba announced an agreement here Wednesday to partner in the development and commercialisation of vaccines with one against the Hepatitis B virus.

The CIGB, Cuba's leading biotechnology institution, has more than 50 research-development projects, while Abivax, based in Paris, is a product of the merger of the Wittycell, Splicos and Zophis firms. Their objective is to fight infectious diseases and cancer.

"Cuba is known for the excellence of its physicians and the quality of its vaccines. This is a project of international importance to put France foremost in this matter," Philippe Pouletty, president of the Administrative Council of the French firm, said.

Norkis Arteaga, head of Biocubafarma business department, said that the complementary nature of both companies in research and production will allow for the distribution of many products in the future.

Arteaga cited in a statement a licensing agreement between the CIGB and Abivax for the development and commercialisation of the therapeutic vaccine against Hepatitis B.

Cuba will provide the clinical results and capacity, while the French firm financial resources to complete other clinical trials in Europe and Asia along with the experience to register it in these markets and commercialise it later.

-- BERNAMA-NNN-PRENSA LATINA

Go here to read the rest:
Cuba, France Agree To Develop Hepatitis B Vaccine

Precise and easy ways to rewrite human genes could finally provide the tools that researchers need to understand and cure some of our most deadly genetic diseases.

Over the last decade, as DNA-sequencing technology has grown ever faster and cheaper, our understanding of the human genome has increased accordingly. Yet scientists have until recently remained largely ham-fisted when theyve tried to directly modify genes in a living cell. Take sickle-cell anemia, for example. A debilitating and often deadly disease, it is caused by a mutation in just one of a patients three billion DNA base pairs. Even though this genetic error is simple and well studied, researchers are helpless to correct it and halt its devastating effects.

Now there is hope in the form of new genome-engineering tools, particularly one called CRISPR. This technology could allow researchers to perform microsurgery on genes, precisely and easily changing a DNA sequence at exact locations on a chromosome. Along with a technique called TALENs, invented several years ago, and a slightly older predecessor based on molecules called zinc finger nucleases, CRISPR could make gene therapies more broadly applicable, providing remedies for simple genetic disorders like sickle-cell anemia and eventually even leading to cures for more complex diseases involving multiple genes. Most conventional gene therapies crudely place new genetic material at a random location in the cell and can only add a gene. In contrast, CRISPR and the other new tools also give scientists a precise way to delete and edit specific bits of DNAeven by changing a single base pair. This means they can rewrite the human genome at will.

It is likely to be at least several years before such efforts can be developed into human therapeutics, but a growing number of academic researchers have seen some preliminary success with experiments involving sickle-cell anemia, HIV, and cystic fibrosis (see table below). One is Gang Bao, a bioengineering researcher at the Georgia Institute of Technology, who has already used CRISPR to correct the sickle-cell mutation in human cells grown in a dish. Bao and his team started the work in 2008 using zinc finger nucleases. When TALENs came out, his group switched quickly, says Bao, and then it began using CRISPR when that tool became available. While he has ambitions to eventually work on a variety of diseases, Bao says it makes sense to start with sickle-cell anemia. If we pick a disease to treat using genome editing, we should start with something relatively simple, he says. A disease caused by a single mutation, in a single gene, that involves only a single cell type.

In little more than a year, CRISPR has begun reinventing genetic research.

Bao has an idea of how such a treatment would work. Currently, physicians are able to cure a small percentage of sickle-cell patients by finding a human donor whose bone marrow is an immunological match; surgeons can then replace some of the patients bone marrow stem cells with donated ones. But such donors must be precisely matched with the patient, and even then, immune rejectiona potentially deadly problemis a serious risk. Baos cure would avoid all this. After harvesting blood cell precursors called hematopoietic stem cells from the bone marrow of a sickle-cell patient, scientists would use CRISPR to correct the defective gene. Then the gene-corrected stem cells would be returned to the patient, producing healthy red blood cells to replace the sickle cells. Even if we can replace 50 percent, a patient will feel much better, says Bao. If we replace 70 percent, the patient will be cured.

Though genome editing with CRISPR is just a little over a year old, it is already reinventing genetic research. In particular, it gives scientists the ability to quickly and simultaneously make multiple genetic changes to a cell. Many human illnesses, including heart disease, diabetes, and assorted neurological conditions, are affected by numerous variants in both disease genes and normal genes. Teasing out this complexity with animal models has been a slow and tedious process. For many questions in biology, we want to know how different genes interact, and for this we need to introduce mutations into multiple genes, says Rudolf Jaenisch, a biologist at the Whitehead Institute in Cambridge Massachusetts. But, says Jaenisch, using conventional tools to create a mouse with a single mutation can take up to a year. If a scientist wants an animal with multiple mutations, the genetic changes must be made sequentially, and the timeline for one experiment can extend into years. In contrast, Jaenisch and his colleagues, including MIT researcher Feng Zhang (a 2013 member of our list of 35 innovators under 35), reported last spring that CRISPR had allowed them to create a strain of mice with multiple mutations in three weeks.

Genome GPS

Go here to read the rest:
CRISPR is the technology that could allow researchers to perform microsurgery on genes

From protecting New Zealand from the mad cow disease to guiding legislation around genetic engineering, Professor Barry Scott has been at the forefront of some of the most important scientific discussions over the past 30 years.

Now his lifes work has been recognised with the New Zealands Association of Scientists top honour, the Marsden Medal.

"Sometimes I think scientists are maniacs with the hours we work, so its nice to be recognised," Professor Scott says. "Im really delighted."

His work has taken him far from the laboratory. He has sat on world-leading boards, spoken at international conferences and helped guide government policy-makers dealing with international dilemmas.

In 1996, he was a member of a committee that advised the New Zealand Government on how to protect agriculture and human health after the outbreak of mad cow disease in Britain. As part of an expert panel, he looked at the implications for New Zealand, its agricultural sector and New Zealanders living in Britain at the time.

As a founding member of Environmental Risk Management Authority, Professor Scott was also been heavily involved in shaping New Zealands policy and decision-making around the introduction of genetically-modified organisms in the 1990s. He was regularly called upon to front public debates on the issue and to help educate people about the underlying science.

Much his work has helped the advancement of New Zealands agricultural sector, including his world-leading research into how an endophyte fungus protects ryegrass from drought, disease and insects.

He is particularly proud of the successes of students he taught and supervised, including more than 20 PhD students now employed in major organisations throughout the world.

Continued here:
Marsden Medal for Barry Scott

Sniff the air around Norman Lewis experimental poplars, and you wont pick up the scent of roses.

But inside the saplings leaves and stems, cells are hard at work producing the chemical called 2-phenylethanol which by any other name would smell as sweet.

Sweeter still is the fact that perfume and cosmetics companies will pay as much as $30 an ounce for the compound that gives roses their characteristic aroma. Because what Lewis and his colleagues at Washington State University are really chasing is the smell of money.

Born out of the frustrating quest to wring biofuels from woody plants, the WSU project takes a different tack. Instead of grinding up trees to produce commercial quantities of so-called cellulosic ethanol, their goal is to turn poplars into living factories that churn out modest levels of chemicals with premium price tags.

The potential market for specialty chemicals many of which are now synthesized from petroleum is big, said Lewis, director of WSUs Institute of Biological Chemistry. Hes already patented some of the technology, which relies on genetic engineering, and created a spinoff company called Elasid.

In the longer term, the profits from high-end products could boost the struggling biofuel industry by helping companies survive whats called the valley of death the point where firms need to scale up production, but money is hard to come by.

The ideal operation would combine the two product lines, extracting valuable chemicals and using the waste for biofuel. But thats a long way off, Lewis said.

Biofuels dont provide a compelling economic case at this point in time, he said. Weve been trying for many decades to understand how plants make these special chemicals that can be used in flavorings, fuels and medicinals, and that seemed like the obvious first place to target.

But failures outnumber successes in the world of green technology, and it remains to be seen whether Lewis and his group will buck the trend.

Costs and controversy

View post:
Rose scent in poplar trees? WSU turns to genetic engineering

Sugar industry can be revived with the help of Tissue Culture Genetic Engineering in UP.
02 February 2014, Shri Narendra Modi highlight the growth of cooperatives in Gujarat which along with focusing on tissue culture, genetic engineering and dri...

By: Bharatiya Janata Party

Here is the original post:
Sugar industry can be revived with the help of Tissue Culture & Genetic Engineering in UP. - Video